Joseph Thome
Stock Analyst at TD Cowen
(3.16)
# 2,906
Out of 5,240 analysts
27
Total ratings
54.17%
Success rate
1.73%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joseph Thome
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Upgrades: Buy | $75 → $90 | $72.72 | +23.76% | 4 | May 8, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $125 → $145 | $111.39 | +30.17% | 4 | May 7, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $275 | $231.05 | +19.02% | 1 | May 6, 2026 | |
| MPLT MapLight Therapeutics | Initiates: Buy | n/a | $29.36 | - | 1 | Apr 7, 2026 | |
| UTHR United Therapeutics | Maintains: Buy | $575 → $660 | $575.79 | +14.63% | 4 | Mar 30, 2026 | |
| ARDX Ardelyx | Maintains: Buy | $9 → $10 | $6.46 | +54.80% | 1 | Oct 31, 2025 | |
| DRUG Bright Minds Biosciences | Initiates: Buy | n/a | $77.64 | - | 1 | May 13, 2025 | |
| VRDN Viridian Therapeutics | Initiates: Buy | n/a | $17.43 | - | 1 | Nov 25, 2024 | |
| RAPP Rapport Therapeutics | Initiates: Buy | n/a | $37.95 | - | 1 | Jul 2, 2024 | |
| ALKS Alkermes | Initiates: Buy | $34 | $38.36 | -11.37% | 1 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $3.13 | - | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.35 | - | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $56.00 | - | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.92 | - | 1 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $120 → $130 | $232.27 | -44.03% | 2 | Jun 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $13.09 | - | 1 | Jan 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.83 | - | 1 | Nov 23, 2021 |
PTC Therapeutics
May 8, 2026
Upgrades: Buy
Price Target: $75 → $90
Current: $72.72
Upside: +23.76%
Mirum Pharmaceuticals
May 7, 2026
Maintains: Buy
Price Target: $125 → $145
Current: $111.39
Upside: +30.17%
Jazz Pharmaceuticals
May 6, 2026
Maintains: Buy
Price Target: $220 → $275
Current: $231.05
Upside: +19.02%
MapLight Therapeutics
Apr 7, 2026
Initiates: Buy
Price Target: n/a
Current: $29.36
Upside: -
United Therapeutics
Mar 30, 2026
Maintains: Buy
Price Target: $575 → $660
Current: $575.79
Upside: +14.63%
Ardelyx
Oct 31, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $6.46
Upside: +54.80%
Bright Minds Biosciences
May 13, 2025
Initiates: Buy
Price Target: n/a
Current: $77.64
Upside: -
Viridian Therapeutics
Nov 25, 2024
Initiates: Buy
Price Target: n/a
Current: $17.43
Upside: -
Rapport Therapeutics
Jul 2, 2024
Initiates: Buy
Price Target: n/a
Current: $37.95
Upside: -
Alkermes
Jun 17, 2024
Initiates: Buy
Price Target: $34
Current: $38.36
Upside: -11.37%
Apr 8, 2024
Initiates: Buy
Price Target: n/a
Current: $3.13
Upside: -
Mar 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.35
Upside: -
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $56.00
Upside: -
Dec 12, 2022
Initiates: Outperform
Price Target: n/a
Current: $1.92
Upside: -
Jun 29, 2022
Maintains: Outperform
Price Target: $120 → $130
Current: $232.27
Upside: -44.03%
Jan 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $13.09
Upside: -
Nov 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.83
Upside: -